| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.7M | +339.4% |
| R&D Expense | $130.2M | +54.6% |
| SG&A Expense | $42.4M | +72.9% |
| Operating Income | -$167.9M | -55.9% |
| Pre-tax Income | -$163.9M | -52.3% |
| Income Tax | $0 | — |
| Net Income | -$163.9M | -52.3% |
| EPS (Basic) | -$3.15 | -12.5% |
| EPS (Diluted) | -$3.15 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $32.7M | -83.7% |
| Short-term Investments | $301.8M | +126.9% |
| Current Assets | $345.2M | +0.1% |
| Total Assets | $352.2M | +0.3% |
| Current Liabilities | $27.7M | +73.3% |
| Total Liabilities | $35.8M | +88.0% |
| Stockholders' Equity | $316.3M | -4.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.2M | -30.0% |
| Capital Expenditures | $1.7M | +279.8% |
| Investing Cash Flow | -$174.0M | -208.0% |
| Financing Cash Flow | $122.0M | -51.7% |
| Free Cash Flow | -$116.9M | -31.3% |
| -12.5% |